Overview
Lucie Rihova practices practicing medicine in Brno, Czech Republic.
Ms. Rihova is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Chronic Inflammatory Response Syndrome (CIRS), and Waldenstrom Macroglobulinemia.
She is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lucie Rihova
Is Lucie Rihova a top-rated expert for Monoclonal Gammopathy of Undetermined Significance (MGUS)?
MediFind is an objective health platform that identifies experts based on real-world data. Lucie Rihova is classified as an Distinguished expert for Monoclonal Gammopathy of Undetermined Significance (MGUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lucie Rihova participate in research or clinical trials?
Yes. Lucie Rihova has published 36 articles and abstracts on conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS). You can view a list of Lucie Rihova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Advanced
- Chronic Inflammatory Response Syndrome (CIRS)
- Multiple MyelomaMs. Rihova isAdvanced. Learn about Multiple Myeloma.
- Experienced
- LeukemiaMs. Rihova isExperienced. Learn about Leukemia.
- Myeloproliferative Neoplasms (MPN)Ms. Rihova isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Waldenstrom MacroglobulinemiaMs. Rihova isExperienced. Learn about Waldenstrom Macroglobulinemia.